Search
Now showing items 1-6 of 6
Lopinavir Plus Nucleoside Reverse-transcriptase Inhibitors, Lopinavir Plus Raltegravir, or Lopinavir Monotherapy for Second-line Treatment of HIV (EARNEST): 144-week Follow-up Results From a Randomised Controlled Trial
(Elsevier, 2018-01)
Background Millions of HIV-infected people worldwide receive antiretroviral therapy (ART) in programmes using WHO-recommended standardised regimens. Recent WHO guidelines recommend a boosted protease inhibitor plus raltegravir ...
Nodding Syndrome: Recent Insights into Etiology, Pathophysiology, and Treatment
(Dove press Ltd, 2018-05-24)
Nodding syndrome is an enigmatic neuropsychiatric and epileptiform disorder associated with psychomotor, mental, and physical growth retardation. The disorder affects otherwise previously normal children aged 3–18 years, ...
Perceptions and Beliefs of Lay People From Northern Uganda Regarding Surgery for Diagnosis and Treatment of Cervical Cancer
(John Wiley & Sons, Inc., 2018-05-02)
Objective
To explore perceptions and beliefs of people in a rural community in northern Uganda regarding surgery for the diagnosis and treatment of cervical cancer. The aim of the study was to inform interventions to ...
Turning a Blind Eye and a Deaf Ear to Traditional and Complementary Medicine Practice Does not Make it go Away: A Qualitative Study Exploring Perceptions and Attitudes of Stakeholders Towards the Integration of Traditional and Complementary Medicine into Medical School Curriculum in Uganda
(BioMed Central Ltd, 2018-12-18)
Background: A substantial proportion of healthcare professionals have inadequate understanding of traditional and complementary medicine and often consider their use inappropriate.
Methods: We conducted a qualitative study ...
Risk Factors for Hemorrhagic and Ischemic Stroke in Sub-Saharan Africa
(HINDAWI LTD , ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, ENGLAND, W1T 5HF, 2018-05-31)
Introduction. In sub-Saharan Africa (SSA), there is a significant burden of ischemic stroke (IS) and hemorrhagic stroke (HS), although data on risk factors for each type are sparse. In this systematic review we attempt to ...
Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus – International Task Force
(Indian Journal of Endocrinology and Metabolism, 2018)
For decades, sulfonylureas(SUs) have been important drugs in the antidiabetic therapeutic armamentarium. They have been used as monotherapy as well as combination therapy. Focus on newer drugs and concerns about the risk ...